Trevena

Trevena Inventory

Inventory of Trevena (TRVN) as of Nov 20, 2026.

Inventory

0.00USD

Last updated:

Inventory of Trevena is 2023 0.00 USD. Inventory of Trevena was 2022 906,000.00 USD. It decreases by % lower compared to the previous year.

The Trevena Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2014
0.00 USD
Jan 1, 2015
0.00 USD
Jan 1, 2016
0.00 USD
Jan 1, 2017
0.00 USD
Jan 1, 2020
1.00 USD
Jan 1, 2021
2.35 M USD
Jan 1, 2022
906,000.00 USD
Jan 1, 2023
0.00 USD
The Trevena Inventory history
YEARInventoryYoY
0.00USD-100.00%
906,000.00USD-61.48%
2.35 MUSD+235.20 M%
1.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Trevena Stock analysis

What does Trevena do? Trevena, Inc. develops and commercializes novel medicines for central nervous system disorders, focusing on OLINVO for moderate-to-severe acute pain management in hospitals and ambulatory surgery centers. The company commercializes OLINVO in the United States under its own brand, targeting healthcare providers in acute care settings. TRV250, a non-narcotic migraine treatment with potential for other CNS indications, is in Phase I development in the United Kingdom, with the company advancing its research through its ABLE product platform. Trevena leverages its ABLE platform to identify GPCR-targeted biased ligands, supporting its pipeline development without external partnerships or third-party sales. The company generates revenue through the commercialization of OLINVO in the U.S. acute care market, with healthcare facilities and providers as primary buyers. TRV250 remains in development, with no current sales, but the company anticipates future revenue once it progresses through clinical trials. Trevena’s ABLE platform serves as a foundational asset for discovering new compounds, reducing reliance on external licensing or collaborations. Its focus on G protein pathway selective modulators and biased ligands differentiates its product portfolio in CNS therapeutics. Trevena is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Trevena stock

On Eulerpool you can find the complete historical development of Inventory Trevena since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Trevena historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Trevena

All Key Metrics — Trevena